Health Plans Ask 2nd Circ. To Revive Celgene Cancer Drug Row
By Bryan Koenig · July 30, 2026, 9:35 PM EDT
Health plans and pharmacies backed by Cigna are asking the Second Circuit to revive a proposed class action alleging Bristol-Myers Squibb Co. and its Celgene subsidiary fraudulently obtained patents, filed sham...
To view the full article, register now.